Signalling Pathways Activated by All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Cells

References

• Groopman, J. and Ellman, L. (1979) "Acute promyelocytic leukemia", American Journal of Hematology, 7, 395–408.
   PubMed Web of Science ®Google Scholar
• Huang, ME., Ye, Y.C., Chen, SR., Chai, J.R., Lu, J.X., Zhoa, L., et al. (1988) "Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia", Blood, 72, 567 — 560.
   Google Scholar
• Kakizuka, A., Miller, W.H. Jr., Umesono, K., Warrell, R.P. Jr., Frankel, S.R., Murty, V.V., et al. (1991) "Chromosomal translo-cation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML", Cell, 66, 663–674.
   Google Scholar
• An, M. and Licht, J.D. (1999) "Deconstructing a disease: RARa, its fusion Partners, and their roles in the pathogenesis of acute promyelocytic leukemia", Blood, 93, 3167— 3215.
   Google Scholar
• He, L.Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., et al. (1998) "Distinct interactions of PML-RARa and PLZF-RARa with co-repressors determine differential responses to RA in APL", Nature Genetics, 18, 126–135.
   Google Scholar
• Altucci, L. and Gronmeyer, H. (2001) "The promise of retinoids to fight against cancer", Nature Cancer Reviews, 1, 181–193.
   PubMed Web of Science ®Google Scholar
• Pandolfi, P.P. (2001) "Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia", Human Molecular Genetics, 10, 769–775.
   Google Scholar
• Ruthardt, M., Testa, U., Nervi, C., Ferrucci, P.F., Grignani, F., Puccetti, E., et al. (1997) "Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signaling", Molecular and Cellular Biology, 17, 4859–4869.
   Google Scholar
• Mangelsdorf, DJ., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. (1995) "The nuclear receptor superfamily: The second decade", Cell, 83, 835–839.
   PubMed Web of Science ®Google Scholar
• Glass, C.K. and Rosenfeld, M.G. (2000) "The coregulator exchange in transcriptional functions of nuclear receptors", Genes and Development, 14, 121 — 141.
   Google Scholar
• Kambhampati, S. and Platanias, L.C. (2003) "Mechanisms of action of all-trans-retinoic acid in acute promyelocytic leukaemia", Haema, 6, 149–156.
   Google Scholar
• Tallman, M.S., Nabhan, C., Feusner, J.H. and Rowe, J.M. (2002) "Acute promyelocytic leukemia: evolving therapeutic strategies", Blood, 99, 759–767.
   PubMed Web of Science ®Google Scholar
• Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., et al. (1999) "A randomized comparison of all-trans-retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group", Blood, 94, 1192–11200.
   PubMed Web of Science ®Google Scholar
• Shen, Z.X., Chen, G.Q., Ni, J.H., Li, X.S., Xiong, S.M., Qiu, Q.Y., et al. (1997) "Use of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia (APL), II. Clinical efficacy and pharmacokinetics in relapsed patients", Blood, 89, 3354— 3360.
   Google Scholar
• Bachleitner-Hofmann, T., Kess, M. and Gissilinger, H. (2002) "Arsenic trioxide: acute promyelocytic leukemia and beyond", Leukemia and Lymphoma, 43, 1535 — 1540.
   PubMed Web of Science ®Google Scholar
• Zhao, W.L., Chen, S.J., Shen, Y., Xu, L., Cai, X., Chen, G.Q., et al. (2001) "Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies", Leukemia and Lymphoma, 42, 1265–1273.
   PubMed Web of Science ®Google Scholar
• Ozpolat, B. and Lopez-Berestein, G. (2002) "Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia", Leukemia and Lymphoma, 43, 933–941.
   Google Scholar
• Estey, E., Koller, C., Cortes, J., Reed, P., Freireich, E., Giles, F., et al. (2001) "Treatment of newly diagnosed acute promyelocytic leukemia with liposomal all-trans-retinoic acid", Leukemia and Lymphoma, 42, 309 — 316.
   Google Scholar
• Boylan, J.F. and Gudas, L.J. (1992) "The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells", Journal of Biological Chemistry, 267, 21486 —21491.
   Web of Science ®Google Scholar
• Parrado, A., Chomienne, C. and Padua, R.A. (2000) "Retinoic acid receptor alpha (RARalpha) mutations in human leukemia", Leukemia and Lymphoma, 39, 271 — 282.
   PubMed Web of Science ®Google Scholar
• Testa, U., Grignani, F., Barberi, T., Fagioli, M., Masciulli, R., Ferrucci, P.F., et al. (1994) "PML/RARa + U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentia-tion response to vitamin D3", Cancer Research, 54, 4508 — 4515.
   Google Scholar
• Grignani, F., Valtieri, M., Gabbianelli, M., Gelmetti, V., Botta, R., Luchetti, L., et al. (2000) "PML/RARa fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype", Blood, 96, 1531 — 1537.
   Google Scholar
• Rego, E.M. and Pandolfi, P.P. (2001) "Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models", Seminars in Hematology, 38, 54— 70.
   Google Scholar
• Pollock, J.L., Westervelt, P., Kurichety, A.K., Pelicci, P.G., Grisolano, J.L. and Ley, T.J. (1999) "A bcr-3 isoform of RARa -PML potentiates the development of PML-RARa driven acute promyelocytic leukemia", Proceedings of the National Academy of Sciences USA, 96, 15103–15108.
   PubMed Web of Science ®Google Scholar
• Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., et al. (2002) "Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease", Blood, 100, 59 — 66.
   Google Scholar
• Kelly, L.M., Kutok, J.L., Williams, I.R., Boulton, C.L., Amaral, S.M., Curley, D.P., et al. (2002) "PML/RARa and FLT3-ITD induce an APL-like disease in a mouse model", Proceedings of the National Academy of Sciences USA, 99, 8283–8288.
   PubMed Web of Science ®Google Scholar
• De Botton, S., Chevret, S., Sanz, M., Dombret, H., Thomas, X., Guerci, A., et al. (2000) "Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial", British Journal of Haematology, 111, 801 — 806.
   PubMed Web of Science ®Google Scholar
• Strudwick, S. and Borden, K.L. (2002) "Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities", Leukemia, 16, 1906— 1917.
   Google Scholar
• Wang, Z.G., Ruggero, D., Ronchetti, S., Zhing, S., Gaboli, M., Rivi, R., et al. (1998) "Pml is essential for multiple apoptotic pathways", Nature Genetics, 20, 266–272.
   PubMed Web of Science ®Google Scholar
• Salomoni, P. and Pandolfi, P.P. (2002) "The role of PML in tumor suppression", Cell, 108, 165 — 170.
   Google Scholar
• Zhong, S., Hu, P., Ye, T.Z., Stan, R., Ellis, N.A. and Pandolfi, P.P. (1999) "A role of PML and the nuclear body in genomic stability", Oncogene, 18, 7941–7947.
   Google Scholar
• Zhong, S., Salomoni, P. and Pandolfi, P.P. (2000) "The transcrip-tional role of PML and the nuclear body", Nature Cell Biology, 2, 85 — 90.
   Web of Science ®Google Scholar
• Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., et al. (1994) "Retinoic acid regulates aberrant nuclear localization of PML-RARa in acute promyelocytic leukemia cells", Cell, 76, 345–356.
   Google Scholar
• Grignani, F., Testa, U., Rogaia, D., Ferrucci, P.F., Samoggia, P., Pinto, A., et al. (1996) "Effects on differentiation by the promyelocytic leukemia PML/RARa protein depend on the fusion of the PML protein dimerization and RARa DNA binding domains", EMBO Journal, 15, 4949–4958.
   Google Scholar
• Zhu, J., Koken, M.H., Quignon, F., Chelbi-Alix, M.K., Degos, L., Wang, Z.Y., et al. (1997) "Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelo-cytic leukemia", Proceedings of the National Academy of Sciences USA, 94, 3978–3983.
   PubMed Web of Science ®Google Scholar
• Kawasaki, A., Matsumura, I., Kataoka, Y., Takigawa, E., Nakajima, K. and Kanakura, Y. (2003) "Opposing effects of PML and PML/RARalpha on STAT3 activity", Blood, 101, 3668–3673.
   PubMed Web of Science ®Google Scholar
• Zhu, J., Heyworth, CM., Glasow, A., Huang, Q.-H., Petrie, K., Lanotte, M., et al. (2001) "Lineage restriction of the RARa gene expression in myeloid differentiation", Blood, 98, 2563–2567.
   PubMed Web of Science ®Google Scholar
• Tsai, S., Bartelmez, S., Heyman, R., Damm, K., Evans, R. and Collins, S.J. (1992) "A mutated retinoic acid receptor-a exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line", Genes and Development, 6, 2258 —2269.
   Google Scholar
• Collins, S.J., Robertson, K.A. and Mueller, L. (1990) "Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha)", Molecular and Cellular Biology, 10, 2154–2163.
   PubMed Web of Science ®Google Scholar
• Labrecque, J., Allan, D., Chambon, P., Iscove, N.N., Lohnes, D. and Hoang, T. (1998) "Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alphal and gamma", Blood, 92, 607–615.
   Google Scholar
• Liu, TX., Zhang, J.W., Tao, J., Zhang, R.B., Zhang, Q.H., Zhao, CJ., et al. (2000) "Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells", Blood, 96, 1496 — 1504.
   Google Scholar
• Chatterjee-Kishore, M., Van den Akker, F. and Stark, G.R. (2000) "Association of STATs with relatives and friends", Trends in Cell Biology, 10, 106–111.
   PubMed Web of Science ®Google Scholar
• Benekli, M., Baer, MR., Baumann, H. and Wetzler, M. (2003) "Signal transducer and activator of transcription proteins in leukemias", Blood, 101, 2940–2954.
   Google Scholar
• Levy, D.E. and Darnell, J.E. Jr. (2002) "Stats: transcriptional control and biological impact", Nature Reviews in Molecular and Cellular Biology, 3, 651— 662.
   Web of Science ®Google Scholar
• Rane, S.G. and Reddy, E.P. (2002) "JAKs, STATs and Src kinases in hematopoiesis", Oncogene, 21, 3334— 3358.
   PubMed Web of Science ®Google Scholar
• Platanias, L.C. and Fish, E.N. (1999) "Signaling pathways activated by interferons", Experimental Hematology, 27, 1583 — 1592.
   PubMed Web of Science ®Google Scholar
• Darnell, J.E. Jr., Kerr, I.M. and Stark, G.R. (1994) "Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins", Science, 264, 1415 — 1421.
   Google Scholar
• Darnell, J.E. Jr. (1997) "Stats and gene regulation", Science, 277, 1630 — 1635.
   Web of Science ®Google Scholar
• Darnell, J.E. Jr. (1998) "Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway", Journal of Interferon and Cytokine Research, 18, 549— 554.
   PubMed Web of Science ®Google Scholar
• Gianni, M., Terao, M., Fortino, I., LiCalzi, M., Viggiano, V., Barbui, T., et al. (1997) "Statl is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells", Blood, 89, 1001 — 1012.
   Google Scholar
• Matikainen, S., Lehtonen, A., Sareneva, T. and Julkunen, I. (1998) "Regulation of IRF and STAT gene expression by retinoic acid", Leukemia and Lymphoma, 30, 63–71.
   Google Scholar
• Pelicano, L., Li, F., Schindler, C. and Chelbi-Alix, M.K. (1997) "Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action", Oncogene, 15, 2349–2359.
   PubMed Web of Science ®Google Scholar
• Chelbi-Alix, M.K. and Pelicano, L. (1999) "Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells", Leukemia, 8, 1167 — 1174.
   Google Scholar
• Dimberg, AT., Karlberg, I., Nilsson, K. and Oberg, F.G. (2003) "Ser-727/Tyr-701 phosphorylated Statl is required for the regula-tion of c-Myc, cyclins, and p27Kip 1 associated with ATRA-induced G0/G1 arrest of U-937 cells", Blood, 102, 254 — 261.
   Web of Science ®Google Scholar
• Dimberg, A., Bahram, F., Karlberg, I., Larsson, L.G., Nilsson, K. and Oberg, F. (2002) "Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27 (Kip 1)", Blood, 99, 2199 — 2206.
   PubMed Web of Science ®Google Scholar
• Nason-Burchenal, K., Gandini, D., Botto, M., Allopenna, J., Seale, J.R., Cross, N.C., et al. (1996) "Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line", Blood, 88, 3926 — 3936.
   Google Scholar
• Gaboli, M., Gandini, D., Delva, L., Wang, Z.G. and Pandolfi, P.P. (1998) "Acute promyelocytic leukemia as a model for cross-talk between interferon and retinoic acid pathways: from molecular biology to clinical applications", Leukemia and Lymphoma, 30, 11 — 22.
   PubMed Web of Science ®Google Scholar
• Katagiri, K., Yokoyama, K.K., Yamamoto, T., Omura, S., Irie, S. and Katagiri, T. (1996) "Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells", Journal of Biological Chemistry, 271, 11557 — 11562.
   Web of Science ®Google Scholar
• Welch, H. and Maridonneau-Parini, I. (1997) "Lyn and Fgr are activated in distinct membrane fractions of human granulocytic cells", Oncogene, 15, 2021 — 2029.
   Web of Science ®Google Scholar
• O'Connor, T.J. and Fujita, D.J. (1995) "Differentiation of B16 murine melanoma cells is associated with an increased level of c-SRC", Melanoma Research, 5, 5 — 13.
   Web of Science ®Google Scholar
• Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., et al. (2002) "Roles of activated Src and Stat3 signaling in melanoma tumor cell growth", Oncogene, 21, 7001 —7010.
   Google Scholar
• Garcia, R., Bowman, T.L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C.A., et al. (2001) "Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells", Oncogene, 20, 2499–2513.
   PubMed Web of Science ®Google Scholar
• Lund, T.C., Coleman, C., Horvath, E., Sefton, B.M., Jove, R., Medveczky, M.M., et al. (1999) "The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activity", Cellular Signalling, 11, 789–796.
   PubMed Web of Science ®Google Scholar
• Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R.P. and Jove, R. (1998) "Stat3 activation by Src induces specific gene regulation and is required for cell transformation", Molecular and Cellular Biology, 18, 2545–2552.
   PubMed Web of Science ®Google Scholar
• Alsayed, Y., Moth, S., Uddin, S., Mahmud, N., Druker, B.J., Fish, E.N., et al. (2000) "All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells", Experimental Hematology, 28, 826–832.
   Google Scholar
• Sattler, M. and Salgia, R. (1998) "Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ ABL-transformed cells", Leukemia, 12, 637— 644.
   Google Scholar
• Ahmad, S., Alsayed, Y.M., Druker, B.J. and Platanias, L.C. (1997) "The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein", Journal of Biological Chemistry, 272, 29991–29994.
   Google Scholar
• Fish, E.N., Uddin, S., Korkmaz, M., Majchrzak, B., Druker, B.J. and Platanias, L.C. (1999) "Activation of a CrkL-Stat5 signaling complex by Type I interferons", Journal of Biological Chemistry, 274, 571 — 573.
   Google Scholar
• Platanias, L.C., Uddin, S., Bruno, E., Korkmaz, M., Ahmad, S., Alsayed, Y., et al. (1999) "CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors", Experimental Hematology, 27, 1315 — 1321.
   Google Scholar
• Alsayed, Y., Uddin, S., Ahmad, S., Majchrzak, B., Druker, B.J., Fish, E.N., et al. (2000) "Interferon 7 activates the C3G-Rap 1 signaling pathway", Journal of Immunology, 164, 1800— 1806.
   Web of Science ®Google Scholar
• Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y. and Noda, M. (1989) "A ras-related gene with transformation suppressor activity", Cell, 56, 77–84.
   Google Scholar
• Cook, S., Rubinfeld, B., Albert, I. and McCormick, F. (1993) "RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts", EMBO Journal, 12, 3475–3485.
   PubMed Web of Science ®Google Scholar
• Uddin, S., Alsayed, Y., Grumbach, I., Woodson, J. and Platanias, L.C. (1999) "Cellular pathways activated by interferons in hematopoietic cells", Haema, 2, 192 — 197.
   Google Scholar
• Uddin, S., Gardziola, C., Dangat, A., Yi, T. and Platanias, L.C. (1996) "Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase", Biochemical Biophysical Research Communications, 225, 833–838.
   PubMed Web of Science ®Google Scholar
• Koyasu, S. (2003) "The role of PI3K in immune cells", Nature Immunology, 4, 313–319.
   PubMed Web of Science ®Google Scholar
• Vivanco, I. and Sawyers, C.L. (2002) "The phosphatidylinositol 3-Kinase AKT pathway in human cancer", Nature Reviews in Cancer, 2, 489–501.
   PubMed Web of Science ®Google Scholar
• Sotsios, Y. and Ward, S.G. (2000) "Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemo-kines", Immunology Reviews, 177, 217 — 235.
   Google Scholar
• Bertagnolo, V., Neri, L.M., Marchisio, M., Mischiati, C. and Capitani, S. (1999) "Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid induced granulocytic differentiation of HL-60 cells", Cancer Research, 59, 542 — 546.
   Web of Science ®Google Scholar
• Antonyak, M.A., Boehm, J.E. and Cerione, R.A. (2002) "Phos-phoinositide 3-kinase activity is required for retinoic acid induced expression and activation of the tissue transglutaminase", Journal of Biological Chemistry, 277, 14712–14716.
   PubMed Web of Science ®Google Scholar
• Antonyak, M.A., Singh, U.S., Lee, D.A., Boehm, J.E., Combs, C., Zgola, M.M., et al. (2001) "Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis", Journal of Biological Chemistry 276, 33582 — 33587.
   PubMed Web of Science ®Google Scholar
• Lewandowski, D., Linassier, C., Iochmann, S., Degenne, M., Domenech, J., Colombat, P., et al. (2002) "Phosphatidylinositol 3-kinases are involved in the all-trans-retinoic acid induced upregulation of CD38 antigen on human haematopoietic cells", British Journal of Haematology, 118, 535 — 544.
   Web of Science ®Google Scholar
• Schaeffer, H.J. and Weber, M.J. (1999) "Mitogen-activated protein kinases: specific messages from ubiquitous messengers", Molecular and Cellular Biology, 19, 2435— 2444.
   Google Scholar
• Chang, L. and Karin, M. (2001) "Mammalian MAP kinase signaling cascades", Nature, 410, 37–40.
   Google Scholar
• Dong, C., Davis, R.J. and Flavell, R.A. (2002) "MAP kinases in the immune response", Annual Review of Immunology, 20, 55–72.
   PubMed Web of Science ®Google Scholar
• Davis, R.J. (2000) "Signal transduction by the JNK group of MAP kinases", Cell, 103, 239–252.
   Google Scholar
• Platanias, L.C. (2003) "Map kinase pathways and hematologic malignancies", Blood, 101, 4667–4679.
   Google Scholar
• Rincon, M., Flavell, R.A. and Davis, R.J. (2001) "Signal transduction by MAP kinases in T lymphocytes", Oncogene, 20, 2490–2497.
   Google Scholar
• Platanias, L.C. (2003) "The p38 mitogen-activated protein kinase pathway and its role in interferon signaling", Pharmacology Therapeutics, 98, 129 — 142.
   Web of Science ®Google Scholar
• Yen, A., Roberson, M.S., Varvayanis, S. and Lee, A.T. (1998) "Retinoic acid induced mitogen-activated protein (MAP)/Extra-cellular signal regulated kinase (ERK) kinase- dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest", Cancer research, 58, 3163 — 3172.
   Google Scholar
• Battle, T.E., Roberson, M.S., Zhang, T., Varvayanis, S. and Yen, A. (2001) "Retinoic acid-induced blr 1 expression requires RAR-alpha, RXR, and MAPK activation and uses ERK2 but not JNK/ SAPK to accelerate cell differentiation", European Journal of Cell Biology, 80, 59–67.
   PubMed Web of Science ®Google Scholar
• Miranda, MB., McGuire, T.F. and Johnson, D.E. (2002) "Importance of MEK-1/-2 signaling in monocytic and granulocy-tic differentiation of myeloid cell lines", Leukemia, 16, 683–692.
   PubMed Web of Science ®Google Scholar
• Bost, F., Caron, L., Marchetti, I., Dani, C., Le Marchand-Brustel, Y. and Binetruy, B. (2002) "Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage", Biochemical Journal, 361, 621 —627.
   Google Scholar
• Smith, ER., Smedberg, J.L., Rula, ME., Hamilton, T.C. and Xu, X.X. (2001) "Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiation", Journal of Biological Chemis-try, 276, 32094–32100.
   PubMed Web of Science ®Google Scholar
• Battle, T.E., Levine, R.A. and Yen, A. (2000) "Retinoic acid-induced blr 1 expression promotes ERK2 activation and cell differentiation in HL-60 cells", Experimental Cell Research, 254, 287–298.
   PubMed Web of Science ®Google Scholar
• Lee, H.Y., Walsh, G.L., Dawson, MI., Hong, W.K. and Kurie, J.M. (1998) "All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways", Journal of Biological Chemistry, 273, 7066–7071.
   Google Scholar
• Lee, H.Y., Sueoka, N., Hong, W.K., Mangelsdorf, D.J., Claret, F.X. and Kurie, J.M. (1999) "All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity", Molecular and Cellular Biology, 19, 1973 — 1980.
   Google Scholar
• Xu, Q., Konta, T., Furusu, A., Nakayama, K., Lucio-Cazana, J., Fine, L.G., et al. (2002) "Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect", Journal of Biological Chemistry, 277, 41693–41700.
   PubMed Web of Science ®Google Scholar
• Moreno-Manzano, V., Ishikawa, Y., Lucio-Cazana, J. and Kitamura, M. (1999) "Suppression of apoptosis by all-trans-retinoic acid. Dual intervention in the c-Jun n-terminal kinase-AP-1 pathway", Journal of Biological Chemistry, 274, 20251 — 20258.
   Web of Science ®Google Scholar
• Caelles, C., Gonzalez-Sancho, J.M. and Munoz, A. (1997) "Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway", Genes and Development, 11, 3351–3364.
   PubMed Web of Science ®Google Scholar
• Li, J., Molkentin, J.D. and Colbert, M.C. (2001) "Retinoic acid inhibits cardiac neural crest migration by blocking c-Jun N-terminal kinase activation", Developmental Biology, 232, 351 — 361.
   Google Scholar
• Chung, J., Chavez, P.R., Russell, R.M. and Wang, X.D. (2002) "Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats", Oncogene, 21, 1539 — 1547.
   Google Scholar
• Alsayed, Y., Uddin, S., Mahmud, N., Lekmine, F., Kalvakolanu, D.V., Minnucci, S., et al. (2001) "Activation of Racl and the p38 Map kinase pathway in response to all-trans-retinoic acid", Journal of Biological Chemistry, 276, 4012–4019.
   PubMed Web of Science ®Google Scholar
• Verma, A., Mohindru, M., Deb, D.K., Sassano, A., Kambhampati, S., Ravandi, F., et al. (2002) "Activation of Rae! and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide", Journal of Biological Chemistry, 277, 44988–44995.
   PubMed Web of Science ®Google Scholar